1003-3734
2014 Issue 4
bian zhe tui jian
wang yu mei ;
wang yu mei ;
..............page:364
..............page:369-370
International Pharmacovigilance Flash
ben kan ;
ben kan ;
..............page:371-372
A new anti-hepatitis C virus drug: sofosbuvir
ZENG Jing-ping;ZHANG Yi;Pharmacy Department of Tianjin First Center Hospital;
ZENG Jing-ping;ZHANG Yi;Pharmacy Department of Tianjin First Center Hospital;
..............page:373-376+390
Development of the electronic clinical trials and its future
CHEN Jun-chao;ZHENG Qing-shan;HE Ying-chun;L Ying-hua;LIU Hong-xia;Center for Drug Clinical Research;Shanghai University of Traditional Chinese Medicine;
CHEN Jun-chao;ZHENG Qing-shan;HE Ying-chun;L Ying-hua;LIU Hong-xia;Center for Drug Clinical Research;Shanghai University of Traditional Chinese Medicine;
..............page:377-380+396
Environmental protection systems of pharmaceutical enterprise in developed countries and the enlightenment to China
LIU Wei;FU Yu;LI Jing;CAI Chao-nan;LU Zhao-ming;College of Pharmacy;Zhengzhou University;
LIU Wei;FU Yu;LI Jing;CAI Chao-nan;LU Zhao-ming;College of Pharmacy;Zhengzhou University;
..............page:381-386
Understanding and thinking about investigator-initiated clinical trials
YANG Zhi-min;GENG Ying;GAO Chen-yan;Center for Drug Evaluation;China Food and Drug Administration;Drug Research Institute;Beijing Anding Hospital;Capital Medical University;
YANG Zhi-min;GENG Ying;GAO Chen-yan;Center for Drug Evaluation;China Food and Drug Administration;Drug Research Institute;Beijing Anding Hospital;Capital Medical University;
..............page:387-390
Progress in preclinical research and application of nephrotoxic biomarkers
ZHU Cong;HUANG Zhi-ying;ZHOU Xiao-bing;LI Bo;National Center for Safety Evaluation of Drugs;National Institutes for Food and Drug Control;Center of Preclinical Screening and Evaluation on New Drug;School of Pharmaceutical Sciences;Sun Yat-sen University;
ZHU Cong;HUANG Zhi-ying;ZHOU Xiao-bing;LI Bo;National Center for Safety Evaluation of Drugs;National Institutes for Food and Drug Control;Center of Preclinical Screening and Evaluation on New Drug;School of Pharmaceutical Sciences;Sun Yat-sen University;
..............page:391-396
Pharmacokinetics and absolute bioavailability of HZ08 liposome for injection in Beagle dogs
SUN Miao-miao;SUN Jing;ZHOU Xia;WANG Xiao-lu;DENG Xin;GE Liang;QIAN Hai;DING Ya;HUANG Wen-long;HANG Tai-jun;Department of Pharmaceutical Analysis;China Pharmaceutical University;Jiangsu Institute for Food and Drug Control;Center of Drug Discovery;China Pharmaceutical University;College of Pharmacy;China Pharmaceutical University;
SUN Miao-miao;SUN Jing;ZHOU Xia;WANG Xiao-lu;DENG Xin;GE Liang;QIAN Hai;DING Ya;HUANG Wen-long;HANG Tai-jun;Department of Pharmaceutical Analysis;China Pharmaceutical University;Jiangsu Institute for Food and Drug Control;Center of Drug Discovery;China Pharmaceutical University;College of Pharmacy;China Pharmaceutical University;
..............page:397-402
..............page:402
Determination of residual lactic and glycolic contents in the new excipient poly(lactic-co-glycolic acid)
SHUAI Fang-wen;ZHANG Jia-wei;WANG Xiang-feng;ZHANG Ting;LEI Yu-ping;ZHOU Hong-hao;Hunan Engineering Research Center for Pharmaceutical Excipients;Hunan;ERKANG Pharmaceutical Co.;Ltd.;Institute of Clinical Pharmacology;Central South University;
SHUAI Fang-wen;ZHANG Jia-wei;WANG Xiang-feng;ZHANG Ting;LEI Yu-ping;ZHOU Hong-hao;Hunan Engineering Research Center for Pharmaceutical Excipients;Hunan;ERKANG Pharmaceutical Co.;Ltd.;Institute of Clinical Pharmacology;Central South University;
..............page:403-406
..............page:406
Comparison of US FDA’s clinical review and regulation for biologics and chemical drugs——a case study of type 2 HER2 positive metastatic breast cancer drugs pertuzumab and lapatinib
DONG Ke;LI Da-wei;YAO Li-xin;ZHENG Qiang;Center for Pharmaceutical Information and Engineering Research;Peking University;Department of Industry Engineering and Management;College of Engineering;Peking University;
DONG Ke;LI Da-wei;YAO Li-xin;ZHENG Qiang;Center for Pharmaceutical Information and Engineering Research;Peking University;Department of Industry Engineering and Management;College of Engineering;Peking University;
..............page:407-417
Structural characterization of the therapeutic monoclonal antibody trastuzumab by LC /MS and LC/MS~E
Henry Shion;Asish Chakraborty;YU Ying-qing;CHEN Xi;SUN Qing-long;Scott Berger;CHEN Wei-bin;SONG Lan-kun;Waters Corporation;Waters Technology Co.;Ltd.;
Henry Shion;Asish Chakraborty;YU Ying-qing;CHEN Xi;SUN Qing-long;Scott Berger;CHEN Wei-bin;SONG Lan-kun;Waters Corporation;Waters Technology Co.;Ltd.;
..............page:418-426+431
Progress in application of flow cytometry in the in vitro micronucleus assays
OU Hong-mei;TU Hong-gang;ZHOU Chang-hui;CHANG Yan;Shanghai Institute of Pharmaceutical Industry;National Shanghai Center for New Drug Safety Evaluation & Research;
OU Hong-mei;TU Hong-gang;ZHOU Chang-hui;CHANG Yan;Shanghai Institute of Pharmaceutical Industry;National Shanghai Center for New Drug Safety Evaluation & Research;
..............page:427-431
Recent advances in the study of anti-invasive fungal medication and lead compounds
TANG Hui;ZHAO Lei;ZHAO Xue-mei;YUAN Tian-rong;DONG Qiong;Shandong Provincial Hospital Affiliated to Shandong University;Shandong University of Traditional Chinese Medicine;
TANG Hui;ZHAO Lei;ZHAO Xue-mei;YUAN Tian-rong;DONG Qiong;Shandong Provincial Hospital Affiliated to Shandong University;Shandong University of Traditional Chinese Medicine;
..............page:432-436+444
Research progress in cardiovascular protection by novel antidiabetic drugs
JIANG Yan;HE You-hu;The Second Affliated Hospital of Nanchang University;
JIANG Yan;HE You-hu;The Second Affliated Hospital of Nanchang University;
..............page:437-440
AGEs-RAGE system and anti-tumor effect of metformin
ZHANG Xia;LIU Jian-ying;Department of Endocrinology;The First Affiliated Hospital of Nanchang University;
ZHANG Xia;LIU Jian-ying;Department of Endocrinology;The First Affiliated Hospital of Nanchang University;
..............page:441-444
Design and special considerations of the pharmacokinetic study in the elderly
LI Min;HU Xin;LI Ke-xin;Beijing Key Laboratory of Drug Clinical Risk and Personalized Medication Evaluation;Department of Pharmacy;Beijing Hospital;
LI Min;HU Xin;LI Ke-xin;Beijing Key Laboratory of Drug Clinical Risk and Personalized Medication Evaluation;Department of Pharmacy;Beijing Hospital;
..............page:445-448+461
A comparison of intracoronary with intravenous glycoprotein IIb /IIIa inhibitors during percutaneous coronary intervention: a Meta-analysis
XU Bing;CHEN Mei;GU Yong-li;SUN Jie;Department of Pharmacy;The First People’s Hospital of Lianyungang;Department of Clinical Pharmacy;Chinese Pharmaceutical University;
XU Bing;CHEN Mei;GU Yong-li;SUN Jie;Department of Pharmacy;The First People’s Hospital of Lianyungang;Department of Clinical Pharmacy;Chinese Pharmaceutical University;
..............page:449-456
Intestinal absorption kinetics of scutellarein in rats
HUANG Yong;TANG Li;LIU Yue;LU Yuan;ZHANG Zhi-rong;LI Yong-jun;Provincial Key Laboratory of Pharmaceutics in Guizhou Province;School of Pharmacy;Guiyang Medical College;Engineering Research Center for the Development and Application of Ethnic Medicines and TCM;Ministry of Education;
HUANG Yong;TANG Li;LIU Yue;LU Yuan;ZHANG Zhi-rong;LI Yong-jun;Provincial Key Laboratory of Pharmaceutics in Guizhou Province;School of Pharmacy;Guiyang Medical College;Engineering Research Center for the Development and Application of Ethnic Medicines and TCM;Ministry of Education;
..............page:457-461
Graphical synthetic routes of bosutinib
HAN Jin-e;CHEN Jian-li;LIN Feng;Shanghai Institute of Pharmaceutical Industry;
HAN Jin-e;CHEN Jian-li;LIN Feng;Shanghai Institute of Pharmaceutical Industry;
..............page:462-464
Influences of PLGA /PLA and microsphere blends on the release of rotigotine from the microspheres
ZHANG Jing-wei;WANG Ai-ping;LI Pei;LIANG Rong-cai;LIU Wan-hui;SUN Kao-xiang;School of Pharmacy;Yantai University;State Key Laboratory of Long-Acting and Targeting Drug Delivery System;Shandong Lüye Pharmaceutical Co.;Ltd.;
ZHANG Jing-wei;WANG Ai-ping;LI Pei;LIANG Rong-cai;LIU Wan-hui;SUN Kao-xiang;School of Pharmacy;Yantai University;State Key Laboratory of Long-Acting and Targeting Drug Delivery System;Shandong Lüye Pharmaceutical Co.;Ltd.;
..............page:465-469
Preparation and properties of ethinylestradiol solid dispersion
WANG Yan-kun;NING Mei-ying;LIU You-ping;Shenyang Pharmaceutical University;Centre of Drugs and Medical Polymer Materials;National Research Institute for Family Planning;
WANG Yan-kun;NING Mei-ying;LIU You-ping;Shenyang Pharmaceutical University;Centre of Drugs and Medical Polymer Materials;National Research Institute for Family Planning;
..............page:470-475+479
Effect of continuous oral cycloastragenol on the activity of cytochrome P450 enzymes in rats
WEI Bao-hong;YE Jing;XUE Bao-juan;SUN Gui-xia;YANG Xiao-yan;ZHANG Yu-jie;School of Chinese Materia Medica;Beijing University of Chinese Medicine;
WEI Bao-hong;YE Jing;XUE Bao-juan;SUN Gui-xia;YANG Xiao-yan;ZHANG Yu-jie;School of Chinese Materia Medica;Beijing University of Chinese Medicine;
..............page:476-479
Analysis of related substances in cefuroxime axetil by LC-MS /MS
LIANG Sheng;HU Juan-ni;WU Qi-qi;LI Xiao-yan;LI Wen-li;HU Chang-qin;DING Li-xia;Hunan Institute for Food and Drug Control;School of Pharmacy;Central South University;National Institute for Food and Drug Control;
LIANG Sheng;HU Juan-ni;WU Qi-qi;LI Xiao-yan;LI Wen-li;HU Chang-qin;DING Li-xia;Hunan Institute for Food and Drug Control;School of Pharmacy;Central South University;National Institute for Food and Drug Control;
..............page:480-485
Adverse drug reactions induced by montelukast
CHENG Jun;Pharmaceutical Affair Office;the Third People’s Hospital of Bengbu;
CHENG Jun;Pharmaceutical Affair Office;the Third People’s Hospital of Bengbu;
..............page:486-488+492
Risk intervention of children’s expectorant medicines
MA Hui;JIN Dan;ZHAO Pin;WANG Chun-ting;WEI Jing;TIAN Chun-hua;DU Xiao-xi;Liaoning Adverse Drug Reaction Monitoring Center;Shenyang Pharmaceutical University;National Center for;ADR Monitoring;
MA Hui;JIN Dan;ZHAO Pin;WANG Chun-ting;WEI Jing;TIAN Chun-hua;DU Xiao-xi;Liaoning Adverse Drug Reaction Monitoring Center;Shenyang Pharmaceutical University;National Center for;ADR Monitoring;
..............page:489-492